Chile vs Fiji: New cases tested for RR-/MDR-TB
Chile
100.0%
in 2024
Fiji
100.0%
in 2024
Chile rank
1st
Fiji rank
1st
New cases tested for RR-/MDR-TB over time
- Chile
- Fiji
How they compare
Chile currently reports 100.0% against 100.0% in Fiji, a difference of 0.0%.
The two have swapped places 6 times across 18 shared years of data; in 2006 it was Fiji ahead.
Chile ranks 1st and Fiji ranks 1st of 192 countries.
Across the 3 decades both report, Chile averaged higher in 2 and Fiji in 1.
Head to head by decade
| Decade | Chile | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.7% | 20.8% | 15.2% | Fiji |
| 2010s | 53.6% | 48.0% | 5.6% | Chile |
| 2020s | 95.2% | 79.2% | 16.0% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Chile or Fiji?
- Chile, at 100.0% against 100.0% in Fiji as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Chile and Fiji?
- 0.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Fiji?
- 18 years are reported by both, from 2006 to 2024.
- How do Chile and Fiji rank globally for new cases tested for rr-/mdr-tb?
- Chile ranks 1st and Fiji ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.